UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 34.861
NA - Nord America 24.994
EU - Europa 7.817
SA - Sud America 2.456
AF - Africa 301
OC - Oceania 211
Continente sconosciuto - Info sul continente non disponibili 21
Totale 70.661
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.504
HK - Hong Kong 23.297
SG - Singapore 5.152
CN - Cina 2.482
BR - Brasile 1.829
VN - Vietnam 1.748
IT - Italia 1.704
UA - Ucraina 1.439
RU - Federazione Russa 950
DE - Germania 879
IE - Irlanda 654
FR - Francia 554
KR - Corea 485
TR - Turchia 443
SE - Svezia 356
FI - Finlandia 322
GB - Regno Unito 307
IN - India 263
CA - Canada 260
AR - Argentina 233
BD - Bangladesh 216
EE - Estonia 146
JP - Giappone 130
MX - Messico 128
IQ - Iraq 105
NZ - Nuova Zelanda 105
AU - Australia 100
EC - Ecuador 96
NL - Olanda 95
PL - Polonia 82
CO - Colombia 79
ZA - Sudafrica 74
PK - Pakistan 72
ID - Indonesia 69
ES - Italia 68
AT - Austria 64
VE - Venezuela 63
UZ - Uzbekistan 52
MA - Marocco 50
CL - Cile 49
PY - Paraguay 41
MY - Malesia 39
SA - Arabia Saudita 38
CZ - Repubblica Ceca 32
KE - Kenya 32
PH - Filippine 29
IL - Israele 25
EG - Egitto 23
AE - Emirati Arabi Uniti 22
AZ - Azerbaigian 22
PE - Perù 21
UY - Uruguay 21
BO - Bolivia 20
CH - Svizzera 20
DZ - Algeria 20
ET - Etiopia 20
JO - Giordania 19
LT - Lituania 18
DO - Repubblica Dominicana 17
EU - Europa 16
JM - Giamaica 16
CR - Costa Rica 15
OM - Oman 15
TN - Tunisia 15
AL - Albania 14
BE - Belgio 14
LB - Libano 14
NP - Nepal 14
KZ - Kazakistan 13
BG - Bulgaria 11
HN - Honduras 11
MN - Mongolia 9
PS - Palestinian Territory 9
BW - Botswana 8
BY - Bielorussia 8
GE - Georgia 8
GR - Grecia 8
IR - Iran 8
BA - Bosnia-Erzegovina 7
CI - Costa d'Avorio 7
DK - Danimarca 7
HU - Ungheria 7
PA - Panama 7
BH - Bahrain 6
KG - Kirghizistan 6
KH - Cambogia 6
PR - Porto Rico 6
QA - Qatar 6
RS - Serbia 6
SN - Senegal 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
ME - Montenegro 5
NG - Nigeria 5
NI - Nicaragua 5
PT - Portogallo 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
AO - Angola 4
Totale 70.537
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.265
Ann Arbor 4.156
Singapore 2.479
San Jose 2.342
Wilmington 2.251
Jacksonville 1.733
Princeton 1.634
Chandler 1.536
Ashburn 1.197
Dallas 1.166
Houston 754
Woodbridge 616
Dublin 613
Council Bluffs 583
The Dalles 490
Lauterbourg 479
Beijing 468
Dong Ket 459
Ho Chi Minh City 413
Nanjing 399
Andover 368
Izmir 365
Moscow 316
Boardman 299
Hanoi 294
Los Angeles 269
Pellezzano 264
New York 234
Düsseldorf 216
Mestre 203
São Paulo 167
Naples 163
Tallinn 146
Norwalk 143
Santa Clara 142
Shenyang 134
Fairfield 131
Salerno 122
Hebei 121
Munich 121
Tokyo 116
Memphis 115
Changsha 113
Nanchang 108
Dearborn 107
Frankfurt am Main 94
Jiaxing 85
Rome 78
Montreal 72
Da Nang 69
Milan 68
Buffalo 65
Nuremberg 65
Warsaw 65
Brooklyn 64
Orem 61
Rio de Janeiro 61
Redwood City 60
Haiphong 58
Chicago 57
Pune 56
Tianjin 56
San Diego 53
Amsterdam 52
San Francisco 50
Tashkent 47
Columbus 46
Baghdad 44
Stockholm 44
Auckland 43
Sydney 43
Curitiba 42
Seattle 41
Belo Horizonte 39
Phoenix 39
Seoul 39
Washington 39
Atlanta 38
Boston 37
Chennai 37
Denver 37
Brasília 36
Turku 35
West Jordan 35
Johannesburg 34
London 32
Cambridge 31
Poplar 31
Quito 30
Jinan 29
Casoria 28
Guangzhou 28
Guayaquil 28
Toronto 28
Biên Hòa 27
Hải Dương 27
Ottawa 27
Nairobi 26
Porto Alegre 26
Shanghai 25
Totale 54.317
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.191
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 995
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 959
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 934
Trial of Deferiprone in Parkinson's Disease 685
Sex Differences in Parkinson’s Disease: From Bench to Bedside 652
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 612
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 597
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 593
Cognitive impairment in nondemented Parkinson's disease. 583
Gender differences in microRNA expression in levodopa-naive PD patients 560
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 549
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 547
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 545
A simulation tool to plan daily nurse requirements 533
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 526
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 521
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 506
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 477
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 468
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 461
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 450
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 450
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 433
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 431
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 422
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 410
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 399
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 399
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 392
Neurotransmission in Parkinson's disease: beyond dopamine. 378
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 373
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 356
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 353
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 333
Bilateral facial palsy after COVID-19 vaccination 327
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 325
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 323
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 322
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 322
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 315
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 309
A novel phenotype in an Italian family with a rare progranulin mutation 305
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 298
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 294
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 286
Trial of Cinpanemab in Early Parkinson's Disease 285
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 277
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 270
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 269
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 263
Classifying Different Stages of Parkinson’s Disease Through Random Forests 262
Metabolomics in Parkinson's disease 260
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 248
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 241
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 237
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 221
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 214
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 211
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 210
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 203
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 202
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 197
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 195
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study 193
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 193
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 190
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 190
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 187
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 183
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 179
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 178
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 176
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 174
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 173
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 173
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 171
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 169
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 167
The natural history of multiple system atrophy: A prospective European cohort study 167
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 167
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 163
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 163
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 163
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 160
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 158
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 158
Affective theory of mind in patients with Parkinson's disease: comment 157
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 157
SAND: a Screening for Aphasia in NeuroDegeneration. Development and normative data 154
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 154
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 150
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 150
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 149
Quitting smoking: An early non-motor feature of Parkinson's disease? 148
Increased bilirubin levels in de novo Parkinson's disease 148
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 148
Normative data for the Montreal Cognitive Assessment in an Italian population sample 147
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 147
Abnormal eating behaviors in progressive supranuclear palsy. 145
Totale 32.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.447
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021563 0 0 0 0 0 0 0 0 0 0 0 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202640.720 4.870 11.165 9.973 1.342 2.392 1.264 4.019 842 1.108 2.363 796 586
Totale 71.755